Allurion Technologies Inc. Share Price

Equities

ALUR

US02008G1022

Software

Market Closed - Nyse 21:00:02 14/05/2024 BST 5-day change 1st Jan Change
2.11 USD +8.76% Intraday chart for Allurion Technologies Inc. +2.43% -43.58%
Sales 2024 * 62.05M 4.93B Sales 2025 * 77.85M 6.18B Capitalization 92.92M 7.38B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.5 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.19 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 503
Yield 2024 *
-
Yield 2025 *
-
Free-Float 76.19%
More Fundamentals * Assessed data
Dynamic Chart
1 day+8.76%
1 week+2.43%
Current month+4.98%
1 month-9.83%
3 months-27.99%
6 months-52.48%
Current year-43.58%
More quotes
1 week
1.75
Extreme 1.7517
2.30
1 month
1.75
Extreme 1.7517
2.50
Current year
1.56
Extreme 1.56
3.95
1 year
1.56
Extreme 1.56
9.00
3 years
1.56
Extreme 1.56
9.00
5 years
1.56
Extreme 1.56
9.00
10 years
1.56
Extreme 1.56
9.00
More quotes
Date Price Change Volume
14/05/24 2.11 +8.76% 174,507
13/05/24 1.94 -1.02% 41,061
10/05/24 1.96 -7.98% 72,872
09/05/24 2.13 +0.47% 26,351
08/05/24 2.12 +2.91% 84,384

Delayed Quote Nyse, May 14, 2024 at 09:00 pm

More quotes
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.94 USD
Average target price
5 USD
Spread / Average Target
+157.73%
Consensus

Quarterly revenue - Rate of surprise